About Global Coalition for Adaptive Research
Global Coalition for Adaptive Research is a company based in Lexington (United States) founded in 2017. It operates as a B2B and Non-profit Collaboration. The company has 21 employees as of December 31, 2022. Global Coalition for Adaptive Research offers products and services including GBM AGILE, REMAP-CAP, and Ovarian CanceRx. Global Coalition for Adaptive Research operates in a competitive market with competitors including Vial, Javara Research, Alcanza Clinical Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.
- Headquarter Lexington, United States
- Employees 21 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Global Coalition For Adaptive Research (Gcar)
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
21
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Global Coalition for Adaptive Research
Global Coalition for Adaptive Research offers a comprehensive portfolio of products and services, including GBM AGILE, REMAP-CAP, and Ovarian CanceRx.
Adaptive trial evaluating treatments for glioblastoma.
Platform trial for COVID-19 treatments and responses.
Trial focused on ovarian cancer therapies development.
People of Global Coalition for Adaptive Research
Unlock access to complete
Funding Insights of Global Coalition for Adaptive Research
Detailed funding history for Global Coalition for Adaptive Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Global Coalition for Adaptive Research
Investment portfolio details for Global Coalition for Adaptive Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Global Coalition for Adaptive Research
Detailed financials for Global Coalition for Adaptive Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Global Coalition For Adaptive Research Comparisons
Peer comparison for Global Coalition for Adaptive Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Global Coalition for Adaptive Research
Global Coalition for Adaptive Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vial, Javara Research, Alcanza Clinical Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare data capture, clinical trials, and CRO services are provided.
|
|
| Locked | Locked | Locked |
Clinical trials for pharmaceuticals are conducted across therapeutic areas.
|
|
| Locked | Locked | Locked |
Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation
|
|
| Locked | Locked | Locked |
Clinical research unit for phase I, II and III trials
|
|
| Locked | Locked | Locked |
Early-phase oncology clinical trials and research services are provided.
|
Detailed competitors of Global Coalition for Adaptive Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Global Coalition For Adaptive Research
Complete news archive for Global Coalition for Adaptive Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Global Coalition for Adaptive Research
Global Coalition for Adaptive Research was founded in 2017.
Global Coalition for Adaptive Research is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
As of Dec 31, 2022, the latest employee count at Global Coalition for Adaptive Research is 21.
Global Coalition for Adaptive Research is a nonprofit that develops and sponsors master protocols and adaptive platform trials to accelerate treatment discovery for rare and deadly diseases. It collaborates with investigators and partners to design innovative trials for conditions like glioblastoma and COVID-19. Based in Larkspur, California, USA, GCAR focuses on efficient, seamless research to improve patient outcomes through international trial sites and scientific expertise.
Global Coalition for Adaptive Research's top competitors include Javara Research, Vial and The START Center for Cancer Research.
Global Coalition for Adaptive Research offers GBM AGILE, REMAP-CAP, and Ovarian CanceRx.